Fox Chase Cancer Center Receives Fourth Straight Accreditation from the National Accreditation Program for Breast Centers

PHILADELPHIA (August 2, 2018) – Fox Chase Cancer Center has successfully renewed its accreditation from the National Accreditation Program for Breast Centers (NAPBC).

The NAPBC is the premier accreditation for breast centers throughout the United States. The accreditation process encompasses 28 individual standards of breast care, extending from benign to malignant disease. It incorporates the evaluation of standards of treatment, as well as components of care including coordination of care via nurse navigation, support services, the credentials of the clinicians and nurses, and quality improvement initiatives.

Every three years breast centers must apply for reaccreditation, which measures performance based on the current NAPBC Standards Manual.

“Fox Chase was one of the first programs to put itself up for evaluation by the NAPBC,” said Richard J. Bleicher, MD, FACS, professor of surgical oncology and leader of the breast program at Fox Chase. “We hold our program to the highest standards of care for our patients and strive to align ourselves with the guidelines set by leading organizations like NAPBC.”

This is the fourth consecutive time Fox Chase has received accreditation.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427